Results 161 to 170 of about 5,635 (193)
Gain-of-Function Mutations in Granulocyte Colony–Stimulating Factor Receptor (CSF3R) Reveal Distinct Mechanisms of CSF3R Activation [PDF]
Granulocyte colony-stimulating factor (G-CSF or CSF3) and its receptor CSF3R regulate granulopoiesis, neutrophil function, and hematopoietic stem cell mobilization. Recent studies have uncovered an oncogenic role of mutations in the CSF3R gene in many hematologic malignancies. To find additional CSF3R mutations that give rise to cell transformation, we
Haijiao Zhang +2 more
exaly +3 more sources
A Congenital CSF3R Mutation in Chronic Neutropenia Reveals a Vital Role for a Cytokine Receptor Extracellular Hinge Motif in the Response to Granulocyte Colony-Stimulating Factor [PDF]
We describe a patient with congenital neutropenia (CN) with a homozygous germline mutation in the colony-stimulating factor 3 receptor gene (CSF3R).
Vincent H J van der Velden +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Archives of Dermatological Research, 2015
Melanogenic paracrine and autocrine cytokine networks have recently been discovered in vitro between melanocytes and other types of skin cells. Granulocyte colony-stimulating factor receptor (CSF3R) controls the survival, proliferation and differentiation of many kinds of cells, including neutrophils. To understand the function of CSF3R and recombinant
Yan Lu, Wen-Yuan Zhu
exaly +3 more sources
Melanogenic paracrine and autocrine cytokine networks have recently been discovered in vitro between melanocytes and other types of skin cells. Granulocyte colony-stimulating factor receptor (CSF3R) controls the survival, proliferation and differentiation of many kinds of cells, including neutrophils. To understand the function of CSF3R and recombinant
Yan Lu, Wen-Yuan Zhu
exaly +3 more sources
CSF3R, SETBP1 And CALR Mutations in Chronic Neutrophilic Leukemia [PDF]
The WHO 2008 definition of chronic neutrophilic leukemia (CNL) is based on clinical and laboratory parameters but not on molecular abnormalities. Mutations in CSF3R, SETBP1 and CALR are reported in patients with chronic neutrophilic leukemia (CNL). However, because CNL is rare, there are few large studies of this issue.
Yajuan Cui, Qian Jiang, Robert Gale
exaly +3 more sources
Distribution of Different Classes of CSF3R Mutations and Co-Mutational Pattern in 360 Myeloid Neoplasia [PDF]
: The colony-stimulating factor 3 receptor (CSF3R) plays an essential role in differentiation, growth, and survival of granulocytes. Driver mutations in CSF3R gene represent a diagnostic marker of chronic neutrophilic leukemia (CNL). Less commonly, these
Monica Maccaferri +2 more
exaly +2 more sources
Chronic myelomonocytic leukemia (CMML) is a hematological neoplasm characterized by monocytosis, splenomegaly, thrombocytopenia, and anemia. Moreover, it is associated with SRSF2 mutations and, rarely, with CSF3R variants.
Giorgia Simonetti +2 more
exaly +2 more sources
RAS and CSF3R mutations in severe congenital neutropenia
Blood, 2009To the editor: Severe congenital neutropenia (CN), a congenital disorder of hematopoiesis and a preleukemic predisposition, has been used as a model for multistep pathogenesis of leukemia.
Manuela, Germeshausen +3 more
openaire +2 more sources
CSF3R Gene Mutations In Myeloid Malignancy Of Childhood
Blood, 2013Abstract Background Granulocyte colony-stimulating factor (G-CSF; CSF3) and its receptor (G-CSFR; CSF3R) control neutrophil production under basal circumstances and during episodes of bacterial infections.
Hitoshi Sano +12 more
openaire +1 more source
Mutational screens highlight glycosylation as a modulator of CSF3R activity
2022Abstract The colony-stimulating factor 3 receptor (CSF3R) controls the growth of neutrophils, the most abundant type of white blood cell. In healthy neutrophils, signaling is dependent on CSF3R binding to its ligand CSF3. A single amino acid mutation in CSF3R, T618I, instead allows for constitutive, ligand-independent cell growth and ...
Michael J. Hollander +5 more
openaire +1 more source
Blood, 2013
Abstract It has been reported by us and others that approx. 30 % of all patients with congenital neutropenia (CN) acquire CSF3R mutations in their life time. More than 80 % of the CN patients who develop myeloid leukemia (CN/AML) harbour CSF3R mutations. This suggests that they are the first hit in leukemogenesis. However,
Maksim Klimiankou +9 more
openaire +1 more source
Abstract It has been reported by us and others that approx. 30 % of all patients with congenital neutropenia (CN) acquire CSF3R mutations in their life time. More than 80 % of the CN patients who develop myeloid leukemia (CN/AML) harbour CSF3R mutations. This suggests that they are the first hit in leukemogenesis. However,
Maksim Klimiankou +9 more
openaire +1 more source

